Last reviewed · How we verify
Cleanoze®
Cleanoze is a nasal decolonization agent designed to reduce or eliminate pathogenic bacteria from the nasal cavity.
Cleanoze is a nasal decolonization agent designed to reduce or eliminate pathogenic bacteria from the nasal cavity. Used for Nasal decolonization to reduce MRSA and other pathogenic bacterial colonization.
At a glance
| Generic name | Cleanoze® |
|---|---|
| Sponsor | Khon Kaen University |
| Drug class | Antimicrobial nasal decolonization agent |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
The drug targets bacterial colonization in the nasal passages, which serves as a reservoir for infections such as methicillin-resistant Staphylococcus aureus (MRSA) and other nosocomial pathogens. By reducing nasal bacterial burden, it aims to decrease the risk of subsequent systemic infections and healthcare-associated infections.
Approved indications
- Nasal decolonization to reduce MRSA and other pathogenic bacterial colonization
Common side effects
- Nasal irritation
- Local discomfort
Key clinical trials
- Budesonide Irrigation in Allergic Rhinitis (PHASE4)
- Cleanoze® Irrigation Device With Powder Preparation Versus Conventional Irrigation Method for Chronic Rhinitis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |